Israel Englander’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Israel Englander’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-200,000	Closed	-$4.51M	–	4642
2019 Q2	$4.51M	Buy	+200,000	New	+$4.68M	0.01%	1853

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Israel Englander's DCPH Position: Q2 2024 in Review

Israel Englander sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 797,100 shares — an estimated $12.5M sold.

Israel Englander first reported a position in DCPH in Q3 2017 and held it in 27 quarters. The position peaked at $91.6M in Q3 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Israel Englander reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Israel Englander sold 797,100 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $12.5M.
Israel Englander first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 27 quarters.
Israel Englander's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $91.6M in Q3 2019.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.